Avalo Therapeutics (AVTX) EBITDA (2014 - 2026)
Avalo Therapeutics (AVTX) reported EBITDA of -$31.5 million for Q2 2026, compared with -$19.18 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Avalo Therapeutics' EBITDA came in at -$91.25 million; for FY2025, it was -$72.58 million.
- By year, EBITDA came in at -$68.34 million in FY2024, -$27.19 million in FY2023, -$37.27 million in FY2022 and -$80.48 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly EBITDA since Q1 2024.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$20.88 million (Q1 2026), -$19.73 million (Q4 2025) and -$19.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.82 Bn | 1,105.41 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 617.41 Bn | 535.94 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.29 Bn | 474.40 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 368.15 Bn | 322.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.07 Bn | 261.06 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.34 Bn | 191.74 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.00 Bn | 165.20 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Avalo Therapeutics | 533.91 Mn | -158.31 Mn | - | -31.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.50 Mn |
| Mar 31, 2026 | -20.88 Mn |
| Dec 31, 2025 | -19.73 Mn |
| Sep 30, 2025 | -19.14 Mn |
| Jun 30, 2025 | -19.18 Mn |
| Mar 31, 2025 | -14.53 Mn |
| Dec 31, 2024 | -13.24 Mn |
| Sep 30, 2024 | -12.83 Mn |
| Jun 30, 2024 | -9.54 Mn |
| Mar 31, 2024 | -32.73 Mn |
| Dec 31, 2023 | -7.62 Mn |
| Sep 30, 2023 | -2.58 Mn |
| Jun 30, 2023 | -6.76 Mn |
| Mar 31, 2023 | -8.41 Mn |
| Dec 31, 2022 | -8.47 Mn |
| Sep 30, 2022 | 4.48 Mn |
| Jun 30, 2022 | -11.46 Mn |
| Mar 31, 2022 | -20.44 Mn |
| Dec 31, 2021 | -17.32 Mn |
| Sep 30, 2021 | -15.67 Mn |
API Access
Avalo Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();